CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −600 | $70.81 | $42K | 767,780 |
| 2026-05-13 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −10,000 | $12.07 | $121K | 51,923 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $12.07 | $241K | 787,780 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −100 | $67.85 | $7K | 787,680 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,398 | $70.29 | $98K | 786,282 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,802 | $71.37 | $700K | 776,480 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −5,900 | $72.15 | $426K | 770,580 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,800 | $73.12 | $205K | 767,780 |
| 2026-05-12 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $12.07 | $241K | 61,923 |
| 2026-05-11 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $12.07 | $241K | 787,780 |
| 2026-05-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,725 | $64.63 | $629K | 778,055 |
| 2026-05-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,575 | $65.46 | $234K | 774,480 |
| 2026-05-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −6,700 | $66.33 | $444K | 767,780 |
| 2026-05-11 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $12.07 | $241K | 81,923 |
| 2026-05-05 | Connaughton Bernadette Director | Grant or award | +3,796 | 42,294 | ||
| 2026-05-05 | Posard Matthew L. Director | Grant or award | +3,796 | 77,835 | ||
| 2026-05-05 | Posard Matthew L. Director | Grant or award · Option to Purchase Common Stock | +6,040 | 6,040 | ||
| 2026-05-05 | Krishnan Mahesh Director | Grant or award | +3,796 | 14,462 | ||
| 2026-05-05 | Krishnan Mahesh Director | Grant or award · Option to Purchase Common Stock | +6,040 | 6,040 | ||
| 2026-05-05 | Lang James Paul Director | Grant or award | +3,796 | 4,685 |
Page 6 of 26 · 513 trades